The three studies linked here do not actually investigate curcumin or its effects on cognitive function — they examine unrelated topics including aquaporin-4 inhibitors, COVID-19 drug repurposing through network modeling, and a plant compound called platycodin D as a potential antiviral agent. As a result, no summary of curcumin's relationship to cognitive function can be responsibly drawn from this particular set of sources. Readers interested in the evidence base for curcumin and cognition should seek out studies that directly examine that relationship, such as randomized controlled trials or systematic reviews focusing on curcumin supplementation and cognitive outcomes in human populations.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| AER-270 and TGN-020 are not aquaporin-4 water channel blockers | Other | 2024 | Neutral | 85 |
| Modeling COVID-19 disease biology to identify drug treatment candidates | Other | 2022 | Neutral | 80 |
| Platycodin D prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infection<... | Other | 2020 | Neutral | 75 |